Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Boostimmune logo — Developing breakthrough therapies to fight cancer by harness...

Boostimmune

Developing breakthrough therapies to fight cancer by harnessing the power of the immune system through the dedication and expertise of an innovative team.

Founded 2021 Venture round Biotechnology, Health Care +1

General Information

Company Name Boostimmune
Founded Year 2021
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Boostimmune. To contact Boostimmune, visit boostimmune.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Boostimmune compare?

A PDF of Boostimmune and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Boostimmune soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Boostimmune

Boostimmune is a biotech startup founded in 2021, dedicated to developing breakthrough therapies for cancer treatment by leveraging the power of the immune system. The company's slogan, "Developing breakthrough therapies to fight cancer by harnessing the power of the immune system through the dedication and expertise of an innovative team," underlines its commitment to innovation and addressing unmet needs in oncology. Boostimmune focuses on developing antibody-based therapies to modulate the immune system, with a mission to develop advanced anti-cancer therapies by enhancing the human immune system. The company operates in the Biotechnology and Health Care industries. The recent Venture Round investment at 01 January 2023 was led by Company K Partners, showcasing investor confidence in Boostimmune's vision and potential. With a dedicated team of industry experts, Boostimmune is well-positioned to overcome challenges in cancer treatment and make significant contributions to the field.

Business keywords: Biotech, Cancer Treatment, Antibody-based Therapies, Immunotherapy, Oncology, Innovative Mindset, Industry Experts, Immune System Modulation, Cancer Therapy, Medical Innovation

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 1
Company K Partners
Company K Partners
01 Jan 2023
Venture Round Undisclosed 1
Premier Partners
Premier Partners
22 Jun 2022
Non Equity Assistance Undisclosed 1
TIPS Program
14 Jun 2021

Boostimmune Alternatives & Competitors

View All Alternatives
Boostimmune vs
Asylia Therapeutics
Asylia Therapeutics

Innovative therapies reshaping immune responses against autoimmune, cancer, and infectious diseases.

Series A
1 employees
Biotechnology, Health Care
Boostimmune vs
Quentis Therapeutics
Quentis Therapeutics

Developing innovative immuno-therapeutics to combat ER stress and empower the immune system in the f...

Grant
Biotechnology, Health Care
Boostimmune vs
Trillium Therapeutics Inc.
Trillium Therapeutics Inc. United States

Clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer.

Post-IPO Equity
14 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Boostimmune

Developing breakthrough therapies to fight cancer by harnessing the power of the immune system through the dedication and expertise of an innovative team.
Boostimmune was founded in 2021.
Boostimmune operates in Biotechnology, Health Care and Health and Wellness. Its work centres on Biotech, Cancer Treatment, Antibody-based Therapies and Immunotherapy.
Boostimmune has completed 3 funding rounds. The latest funding stage is Venture round.
Top alternatives and competitors to Boostimmune include Asylia Therapeutics, Quentis Therapeutics, Trillium Therapeutics Inc., Antharis Therapeutics, Inc., IRX Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Boostimmune and Asylia Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Boostimmune, https://bouncewatch.com/company/boostimmune, updated 16 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes